Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 79 of 79 entries
Sorted by: Best Match Show Resources per page
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.

Cancers

Mauriello A, Zeuli R, Cavalluzzo B, Petrizzo A, Tornesello ML, Buonaguro FM, Ceccarelli M, Tagliamonte M, Buonaguro L.
PMID: 31756926
Cancers (Basel). 2019 Nov 20;11(12). doi: 10.3390/cancers11121824.

Cancer genome instability leads to accumulation of mutations which may result into tumor-specific mutated "neoantigens", not be affected by central T-cell tolerance. Such neoantigens are considered the optimal target for the patient's anti-tumor T cell immunity as well as...

Cite
Mauriello A, Zeuli R, Cavalluzzo B, et al. High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy. Cancers (Basel). 2019;11(12)doi: 10.3390/cancers11121824.
Mauriello, A., Zeuli, R., Cavalluzzo, B., Petrizzo, A., Tornesello, M. L., Buonaguro, F. M., Ceccarelli, M., Tagliamonte, M., & Buonaguro, L. (2019). High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy. Cancers, 11(12), . https://doi.org/10.3390/cancers11121824
Mauriello, Angela, et al. "High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy." Cancers vol. 11,12 (2019). doi: https://doi.org/10.3390/cancers11121824
Mauriello A, Zeuli R, Cavalluzzo B, Petrizzo A, Tornesello ML, Buonaguro FM, Ceccarelli M, Tagliamonte M, Buonaguro L. High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy. Cancers (Basel). 2019 Nov 20;11(12). doi: 10.3390/cancers11121824. PMID: 31756926; PMCID: PMC6966682.
Copy Download .nbib Format: NLM
Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside.

Vaccines

Siracusano G, Tagliamonte M, Buonaguro L, Lopalco L.
PMID: 31991677
Vaccines (Basel). 2020 Jan 24;8(1). doi: 10.3390/vaccines8010041.

Cell surface proteins act as the go-between in carrying the information from the extracellular environment to the intracellular signaling proteins. However, these proteins are often deregulated in neoplastic diseases, including hepatocellular carcinoma. This review discusses several recent studies that...

Cite
Siracusano G, Tagliamonte M, Buonaguro L, et al. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside. Vaccines (Basel). 2020;8(1)doi: 10.3390/vaccines8010041.
Siracusano, G., Tagliamonte, M., Buonaguro, L., & Lopalco, L. (2020). Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside. Vaccines, 8(1), . https://doi.org/10.3390/vaccines8010041
Siracusano, Gabriel, et al. "Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside." Vaccines vol. 8,1 (2020). doi: https://doi.org/10.3390/vaccines8010041
Siracusano G, Tagliamonte M, Buonaguro L, Lopalco L. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside. Vaccines (Basel). 2020 Jan 24;8(1). doi: 10.3390/vaccines8010041. PMID: 31991677; PMCID: PMC7157713.
Copy Download .nbib Format: NLM
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides.

Journal of translational medicine

Mauriello A, Cavalluzzo B, Manolio C, Ragone C, Luciano A, Barbieri A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L.
PMID: 34952611
J Transl Med. 2021 Dec 24;19(1):526. doi: 10.1186/s12967-021-03194-6.

The host's immune system may be primed against antigens during the lifetime (e.g. microorganisms antigens-MoAs), and swiftly recalled upon growth of a tumor expressing antigens similar in sequence and structure. C57BL/6 mice were immunized in a preventive setting with...

Cite
Mauriello A, Cavalluzzo B, Manolio C, et al. Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides. J Transl Med. 2021;19(1):526doi: 10.1186/s12967-021-03194-6.
Mauriello, A., Cavalluzzo, B., Manolio, C., Ragone, C., Luciano, A., Barbieri, A., Tornesello, M. L., Buonaguro, F. M., Tagliamonte, M., & Buonaguro, L. (2021). Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides. Journal of translational medicine, 19(1), 526. https://doi.org/10.1186/s12967-021-03194-6
Mauriello, Angela, et al. "Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides." Journal of translational medicine vol. 19,1 (2021): 526. doi: https://doi.org/10.1186/s12967-021-03194-6
Mauriello A, Cavalluzzo B, Manolio C, Ragone C, Luciano A, Barbieri A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L. Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides. J Transl Med. 2021 Dec 24;19(1):526. doi: 10.1186/s12967-021-03194-6. PMID: 34952611.
Copy Download .nbib Format: NLM
Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013.

Infectious agents and cancer

Simbiri KO, Biddle J, Kinyera T, Were PA, Tenge C, Kawira E, Masalu N, Sumba PO, Lawler-Heavner J, Stefan CD, Buonaguro FM, Robinson D, Newton R, Harford J, Bhatia K, Mbulaiteye SM.
PMID: 25686906
Infect Agent Cancer. 2014 Sep 11;9:32. doi: 10.1186/1750-9378-9-32. eCollection 2014.

A one-day workshop on Burkitt lymphoma (BL) was held at the 9(th) African Organization for Research and Training in Cancer (AORTIC) conference in 2013 in Durban, South Africa. The workshop featured 15 plenary talks by delegates representing 13 institutions...

Cite
Simbiri KO, Biddle J, Kinyera T, et al. Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013. Infect Agent Cancer. 2014;9:32doi: 10.1186/1750-9378-9-32.
Simbiri, K. O., Biddle, J., Kinyera, T., Were, P. A., Tenge, C., Kawira, E., Masalu, N., Sumba, P. O., Lawler-Heavner, J., Stefan, C. D., Buonaguro, F. M., Robinson, D., Newton, R., Harford, J., Bhatia, K., & Mbulaiteye, S. M. (2014). Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013. Infectious agents and cancer, 932. https://doi.org/10.1186/1750-9378-9-32
Simbiri, Kenneth O, et al. "Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013." Infectious agents and cancer vol. 9 (2014): 32. doi: https://doi.org/10.1186/1750-9378-9-32
Simbiri KO, Biddle J, Kinyera T, Were PA, Tenge C, Kawira E, Masalu N, Sumba PO, Lawler-Heavner J, Stefan CD, Buonaguro FM, Robinson D, Newton R, Harford J, Bhatia K, Mbulaiteye SM. Burkitt lymphoma research in East Africa: highlights from the 9(th) African organization for research and training in cancer conference held in Durban, South Africa in 2013. Infect Agent Cancer. 2014 Sep 11;9:32. doi: 10.1186/1750-9378-9-32. eCollection 2014. PMID: 25686906; PMCID: PMC4163050.
Copy Download .nbib Format: NLM
Potentiating cancer vaccine efficacy in liver cancer.

Oncoimmunology

Tagliamonte M, Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Buonaguro L.
PMID: 30288355
Oncoimmunology. 2018 Jul 23;7(10):e1488564. doi: 10.1080/2162402X.2018.1488564. eCollection 2018.

Hepatocellular carcinoma (HCC) is the most common liver malignancy with a poor prognosis and an overall 5-year survival rate of approximately 5-6%. This is due because standard of care treatment options are limited and none of them shows a...

Cite
Tagliamonte M, Petrizzo A, Mauriello A, et al. Potentiating cancer vaccine efficacy in liver cancer. Oncoimmunology. 2018;7(10):e1488564doi: 10.1080/2162402X.2018.1488564.
Tagliamonte, M., Petrizzo, A., Mauriello, A., Tornesello, M. L., Buonaguro, F. M., & Buonaguro, L. (2018). Potentiating cancer vaccine efficacy in liver cancer. Oncoimmunology, 7(10), e1488564. https://doi.org/10.1080/2162402X.2018.1488564
Tagliamonte, Maria, et al. "Potentiating cancer vaccine efficacy in liver cancer." Oncoimmunology vol. 7,10 (2018): e1488564. doi: https://doi.org/10.1080/2162402X.2018.1488564
Tagliamonte M, Petrizzo A, Mauriello A, Tornesello ML, Buonaguro FM, Buonaguro L. Potentiating cancer vaccine efficacy in liver cancer. Oncoimmunology. 2018 Jul 23;7(10):e1488564. doi: 10.1080/2162402X.2018.1488564. eCollection 2018. PMID: 30288355; PMCID: PMC6169594.
Copy Download .nbib Format: NLM
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides.

Journal of translational medicine

Mauriello A, Cavalluzzo B, Manolio C, Ragone C, Luciano A, Barbieri A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L.
PMID: 34952611
J Transl Med. 2021 Dec 24;19(1):526. doi: 10.1186/s12967-021-03194-6.

The host's immune system may be primed against antigens during the lifetime (e.g. microorganisms antigens-MoAs), and swiftly recalled upon growth of a tumor expressing antigens similar in sequence and structure. C57BL/6 mice were immunized in a preventive setting with...

Cite
Mauriello A, Cavalluzzo B, Manolio C, et al. Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides. J Transl Med. 2021;19(1):526doi: 10.1186/s12967-021-03194-6.
Mauriello, A., Cavalluzzo, B., Manolio, C., Ragone, C., Luciano, A., Barbieri, A., Tornesello, M. L., Buonaguro, F. M., Tagliamonte, M., & Buonaguro, L. (2021). Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides. Journal of translational medicine, 19(1), 526. https://doi.org/10.1186/s12967-021-03194-6
Mauriello, Angela, et al. "Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides." Journal of translational medicine vol. 19,1 (2021): 526. doi: https://doi.org/10.1186/s12967-021-03194-6
Mauriello A, Cavalluzzo B, Manolio C, Ragone C, Luciano A, Barbieri A, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L. Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides. J Transl Med. 2021 Dec 24;19(1):526. doi: 10.1186/s12967-021-03194-6. PMID: 34952611; PMCID: PMC8709997.
Copy Download .nbib Format: NLM
Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19.

STAR protocols

De Domenico E, Bonaguro L, Schulte-Schrepping J, Becker M, Händler K, Schultze JL.
PMID: 33377120
STAR Protoc. 2020 Dec 16;1(3):100233. doi: 10.1016/j.xpro.2020.100233. eCollection 2020 Dec 18.

In December 2019, a new coronavirus, SARS-CoV-2, which causes the respiratory illness that led to the COVID-19 pandemic, was reported. In the face of such a new pathogen, special precautions must be taken to examine potentially infectious materials due...

Cite
De Domenico E, Bonaguro L, Schulte-Schrepping J, et al. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19. STAR Protoc. 2020;1(3):100233doi: 10.1016/j.xpro.2020.100233.
De Domenico, E., Bonaguro, L., Schulte-Schrepping, J., Becker, M., Händler, K., & Schultze, J. L. (2020). Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19. STAR protocols, 1(3), 100233. https://doi.org/10.1016/j.xpro.2020.100233
De Domenico, Elena, et al. "Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19." STAR protocols vol. 1,3 (2020): 100233. doi: https://doi.org/10.1016/j.xpro.2020.100233
De Domenico E, Bonaguro L, Schulte-Schrepping J, Becker M, Händler K, Schultze JL. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19. STAR Protoc. 2020 Dec 16;1(3):100233. doi: 10.1016/j.xpro.2020.100233. eCollection 2020 Dec 18. PMID: 33377120; PMCID: PMC7757730.
Copy Download .nbib Format: NLM
Showing 73 to 79 of 79 entries